Serum Institute of India
Tracked across 3 events · 547 articles · First seen Jan 13, 2025 · Last active Jun 03, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Tech
Global health organizations are accelerating efforts to develop vaccines against the Ebola Bundibugyo strain, which is causing an outbreak in Democratic Republic of the Congo and Uganda. The Coalition for Epidemic Preparedness Innovations (CEPI) has…
Impact: The Serum Institute of India is manufacturing a vaccine candidate developed by the University of Oxford, receiving up to $8.6 million from CEPI for its development.
May 22, 2026 · 36 articles
Tech
The World Health Organization has recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola: Mapp Biopharmaceutical's MBP134, Regeneron Pharmaceuticals' maftivimab, and Gilead Sciences' remdesivir. These, along with other vaccine candidates, are to be…
Impact: The Serum Institute of India collaborated with the University of Oxford to develop ChAdOx1 Bundibugyo, a vaccine candidate for the Ebola Bundibugyo strain.
May 28, 2026 · 6 articles
Accidents
Impact: The Serum Institute of India is manufacturing doses of a vaccine candidate built on the University of Oxford/AstraZeneca platform, which could be used for clinical trials against the Bundibugyo ebolavirus.
May 18, 2026 · 505 articles
70
Serum Institute of India lined up to produceCEPI Funds Ebola...
65
Serum Institute of India making vaccine doses
NEWSDESK
Track Serum Institute of India live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard